Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration

Departments of Neurosurgery, Neurobiology, Genetics, Program on Neurogenetics, Diagnostic Radiology, Neurology, Molecular, Cellular, and Developmental Biology, and Pharmacology, and Howard Hughes Medical Institute, Yale School of Medicine, New Haven, CT 06510.
Proceedings of the National Academy of Sciences (Impact Factor: 9.67). 01/2013; DOI: 10.1073/pnas.1222732110
Source: PubMed


Ubiquitin C-terminal hydrolase-L1 (UCHL1), a neuron-specific de-ubiquitinating enzyme, is one of the most abundant proteins in the brain. We describe three siblings from a consanguineous union with a previously unreported early-onset progressive neurodegenerative syndrome featuring childhood onset blindness, cerebellar ataxia, nystagmus, dorsal column dysfuction, and spasticity with upper motor neuron dysfunction. Through homozygosity mapping of the affected individuals followed by whole-exome sequencing of the index case, we identified a previously undescribed homozygous missense mutation within the ubiquitin binding domain of UCHL1 (UCHL1(GLU7ALA)), shared by all affected subjects. As demonstrated by isothermal titration calorimetry, purified UCHL1(GLU7ALA), compared with WT, exhibited at least sevenfold reduced affinity for ubiquitin. In vitro, the mutation led to a near complete loss of UCHL1 hydrolase activity. The GLU7ALA variant is predicted to interfere with the substrate binding by restricting the proper positioning of the substrate for tunneling underneath the cross-over loop spanning the catalytic cleft of UCHL1. This interference with substrate binding, combined with near complete loss of hydrolase activity, resulted in a >100-fold reduction in the efficiency of UCHL1(GLU7ALA) relative to WT. These findings demonstrate a broad requirement of UCHL1 in the maintenance of the nervous system.

Download full-text


Available from: Sreeganga S Chandra, Nov 21, 2014
  • Source
    • "Lastly, in 2013 three siblings from a Turkish family were discovered with a recessive, missense mutation in the Ub-binding domain of UCHL1 (mutation E7A), which leads to markedly reduced catalytic activity of this DUB in vitro. Patients from this family show an early-onset progressive neurodegenerative syndrome that includes cerebellar ataxia, spasticity, blindness, and nystagmus (Bilguvar et al., 2013). These symptoms are different from those of PD patients, including the ones who carry the I93M mutation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The Ubiquitin-Proteasome Pathway (UPP), which is critical for normal function in the nervous system and is implicated in various neurological diseases, requires the small modifier protein ubiquitin to accomplish its duty of selectively degrading short-lived, abnormal or misfolded proteins. Over the past decade, a large class of proteases collectively known as deubiquitinating enzymes (DUBs) has increasingly gained attention in all manners related to ubiquitin. By cleaving ubiquitin from another protein, DUBs ensure that the UPP functions properly. DUBs accomplish this task by processing newly translated ubiquitin so that it can be used for conjugation to substrate proteins, by regulating the “where, when, and why” of UPP substrate ubiquitination and subsequent degradation, and by recycling ubiquitin for re-use by the UPP. Because of the reliance of the UPP on DUB activities, it is not surprising that these proteases play important roles in the normal activities of the nervous system and in neurodegenerative diseases. In this review, we summarize recent advances in understanding the functions of DUBs in the nervous system. We focus on their role in the UPP, and make the argument that understanding the UPP from the perspective of DUBs can yield new insight into diseases that result from anomalous intra-cellular processes or inter-cellular networks. Lastly, we discuss the relevance of DUBs as therapeutic options for disorders of the nervous system.
    Full-text · Article · Aug 2014 · Frontiers in Molecular Neuroscience
  • Source
    • "A different mutation was found in a rare progressive neurodegenerative disease (Bilguvar et al., 2013). Both mutations lead to the creation of a loss of function protein (Leroy et al., 1998; Bilguvar et al., 2013), indicating that proper de-ubiquitination and UCHL1 amounts are critical to avoid neurodegenerative deterioration. The UCHL1-AS ncRNA binds in its 5′ Region to the coding transcript’s 5′ Region and causes up-regulation of protein levels without affecting mRNA levels (Carrieri et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Neurodegenerative diseases such as late-onset Alzheimer’s disease (LOAD) involve a genetically complex and still obscure ensemble of causative and risk factors accompanied by complex feedback responses. The advent of ‘high-throughput’ transcriptome investigation technologies such as deep sequecing is increasingly being combined with statistical and bioinformatics analysis methods complemented by Bayesian Networks or network and graph analyses. Together, such 'integrative' studies are beginning to identify co-regulated gene networks linked with biological pathways and potentially modulating disease predisposition, outcome and progression. Specifically, bioinformatics analyses of integrated microarray and genotyping data in cases and controls reveal changes in gene expression of both protein-coding and small and long regulatory RNAs; highlight relevant quantitative transcriptional differences between LOAD and non-demented control brains and demonstrate reconfiguration of functionally meaningful molecular interaction structures in LOAD. These may be measured as changes in connectivity in ‘hub nodes’ of relevant gene networks. We illustrate here the open analytical questions in the transcriptome investigation of neurodegenerative disease studies, proposing 'ad-hoc' strategies for the evaluation of differential gene expression and hints for a simple analysis of the ncRNA part of such datasets. We then survey the emerging role of long non-coding RNA in the healthy and diseased brain transcriptome and describe the main current methods for computational modeling of gene networks. We propose accessible modular and pathway-oriented methods and guidelines for bioinformatics investigations of whole transcriptome NGS datasets. We finally present methods and databases for functional interpretations of long ncRNAs and propose a simple heuristic approach to visualize and represent physical and and functional interactions of the coding and non-coding components of the transcriptome
    Full-text · Article · Mar 2014 · Frontiers in Cellular Neuroscience
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Dysregulation of cell proliferation and the cell cycle are associated with various diseases, such as cancers. Cyclin-dependent kinases (CDKs) play central roles in cell proliferation and the cell cycle. Ubiquitin C-terminal hydrolase L1 (UCH-L1) is expressed in a restricted range of tissues, including the brain and numerous types of cancers. However, the molecular functions of UCH-L1 remain elusive. In the present study, we found that UCH-L1 physically interacts with CDK1, CDK4 and CDK5, enhancing their kinase activity. Using several mutants of UCH-L1, we showed that this enhancement is dependent upon interaction levels between UCH-L1 and CDKs, but is independent of the known ubiquitin-related functions of UCH-L1. Gain- and loss-of-function studies revealed that UCH-L1 enhances proliferation of multiple cell types, including human cancer cells. Inhibition of the interaction between UCH-L1 and cell cycle-associated CDK resulted in the abolishment of UCH-L1-induced enhancement of cell proliferation. RNA interference of UCH-L1 reduced the growth of human xenograft tumors in mice. We concluded that UCH-L1 is a novel regulator of the kinase activities of CDKs. We believe our findings from this study will significantly contribute to our understanding of cell cycle-associated diseases.
    Full-text · Article · Mar 2013 · Journal of Biological Chemistry
Show more